Related Experiment Video

Updated: Aug 21, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

Delivering a selective neonatal BCG vaccination programme in a multi-ethnic community: an audit of the neonatal BCG

O Etuwewe1, A Wood, A Lyon

  • 1Birmingham and Solihull Health Protection Unit. jitemo@yahoo.com

Communicable Disease and Public Health
|October 16, 2004
PubMed

Insights

Neonatal bacillus Calmette-Guérin (BCG) immunisation uptake is inconsistent, with only 74% of eligible newborns vaccinated. Guidelines need improvement to address diverse populations and ensure all at-risk infants receive this vital tuberculosis prevention.

Area of Science:

  • Public Health
  • Immunology
  • Pediatrics

Background:

  • Neonatal bacillus Calmette-Guérin (BCG) vaccination is crucial for tuberculosis prevention.
  • Local health professionals noted variability in knowledge regarding BCG eligibility and vaccine uptake.
  • Concerns exist about identifying eligible infants and ensuring adequate vaccination coverage.

Purpose of the Study:

  • To assess the variability in BCG vaccination knowledge and uptake among newborns.
  • To identify factors contributing to inconsistencies in BCG vaccination coverage.
  • To evaluate the adequacy of current national guidelines for diverse populations.

Main Methods:

  • A questionnaire was distributed to health visitors for use during routine infant visits.
  • Data collected included infant demographics (ethnicity, country of origin), BCG eligibility, and vaccination status.
  • Analysis focused on vaccination rates and identification of high-risk groups.

Main Results:

  • BCG vaccination was indicated for 41% of newborns.
  • Overall uptake among eligible infants was 74%, with significant variation (36-83%) across maternity units.
  • Inconsistent identification of high-risk groups by ethnicity and origin led to low coverage in some eligible populations.

Conclusions:

  • Confusion persists regarding tuberculosis risk assessment and BCG vaccination criteria for infants.
  • Current national guidelines are insufficient for addressing diverse family structures and origins.
  • There is a need for clearer national guidelines or pragmatic local guidance to improve BCG vaccination coverage.

More Related Videos

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...